Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Healthcare

igrnews

Sanofi Looks to Cell Culture Tech for Universal Flu Vaccine

Healthcare Oct 24, 2018 at 18:26

Sanofi Looks to Cell Culture Tech for Universal Flu Vaccine

In February 2018-Sanofi, Pasteur has licensed SK Chemicals’ mammalian cell culture platform for vaccine production in a deal worth up to $155m (€126m). The mammalian cell culture technology is used to make SK Chemicals’ commercial trivalent and quadrivalent seasonal influenza vaccines and now Sanofi will use it as part of its own influenza vaccine development programme.

Sanofi Pasteur is actively exploring several innovative influenza vaccine technologies for the future. This includes the development of a broadly protective influenza vaccine that will be designed to protect against influenza without the need to manufacture and administer a vaccine every season.

Increased Applications Especially In the Early Drug Discovery to Promote Growth in the 3D Cell Culture Market

Increase in adoption of 3D cell culture in diagnostic centers, hospitals, and pharmaceutical and biotech companies and rise in demand in organ transplantation, tissue regeneration, and regenerative medicine is driving the growth of the 3D cell culture market. Furthermore, the use of microchips to implement cell culture with micro-fabricated tissue component is anticipated to boost the growth of the 3D cell culture market. However, the lack of Infrastructure is likely to retrain the growth of the 3D cell culture market. The emergence of microfluidics-based 3D cell culture is providing several growth opportunities for the key players in the global 3D cell culture market. In addition, the presence of organizations such as the International Society for Stem Cell Research is fostering scientific growth through financial grants and findings.

North America to Dominate the Global 3D Cell Culture Market

North America region dominated the global 3D cell culture market followed by Europe. The growth in the North America region is due to the presence of well-established pharmaceutical and biotechnology industry. In addition, the presence of several pharma and biotech organizations implementing the technology in collaboration with research laboratories drives North American regional market. The market in the Asia Pacific region is expected to expand at a high CAGR due to growing adoption for 3D cell culture in developing nations.